National Library of Medicine: DailyMed. Emgality—galcanezumab-gnlm injection, solution [drug label]. National Library of Medicine: DailyMed. Vyepti—eptinezumab-jjmr injection [drug label]. American ...
a failed study for migraine drug Vyepti (eptinezumab) designed to expand its use into new markets, and lacklustre results in an alpha-synuclein-targeting drug in multiple system atrophy (MSA).
Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy TA117 24 January 2007 24 January 2007 Methadone and buprenorphine ...
There’s more competition jostling for position however, following the approval of Lundbeck’s Vyepti (eptinezumab), an intravenous drug that only needs to be administered four times a year.